EPCAM and familial pancreatic carcinoma: To test this hypothesis, the binding specificity of Ec1–LoPE to two EpCAM-expressing pancreatic cancer cell lines, BxPC3 and Panc-1, was tested and the affinity of Ec1–LoPE was measured.